Silverback Therapeutics Inc

Company Snapshot
500 Fairview Avenue N
Seattle, WA 98109
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 54
https://www.silverbacktx.com
Please select from the dropdown
Company Financials

2018
2019
2020
Gross Profit
Operating Income
($18,320,000)
($24,067,000)
($32,918,000)
Net Income
($17,579,000)
($23,967,000)
($32,947,000)
2018
Gross Profit
Operating Income
($18,320,000)
Net Income
($17,579,000)
2019
Gross Profit
Operating Income
($24,067,000)
Net Income
($23,967,000)
2020
Gross Profit
Operating Income
($32,918,000)
Net Income
($32,947,000)
The above data on Silverback Therapeutics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Laura Shawver
Director and Chief Executive Officer
$608,356
$13,166,894
$44,475
$13,819,725
Laura Shawver
$13,819,725
Director and Chief Executive Officer
Valerie Odegard,
President and Chief Scientific Officer
$552,384
$6,601,819
$0
$7,154,203
Valerie Odegard,
$7,154,203
President and Chief Scientific Officer
Jonathan Piazza
Chief Financial Officer
$194,890
$5,909,383
$105,000
$6,209,273
Jonathan Piazza
$6,209,273
Chief Financial Officer
Robert Hershberg
Independent Director
$16,597
$1,105,723
$0
$1,122,320
Robert Hershberg
$1,122,320
Independent Director
Jonathan Root
Independent Director
$3,349
$546,519
$0
$549,868
Jonathan Root
$549,868
Independent Director
Silverback Therapeutics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2020. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us